News

Encore is a leader in the health-information analytics and technology services industry focused on healthcare providers. Through its consulting services and solutions, Encore assists customers with a wide

The company said that without treatment, the symptoms of schizoaffective disorder are complex and disabling. At present, there are limited treatment options approved for managing the symptoms of

The deal is aimed at developing new drugs that can benefit the large population of people with unmet needs in the pain management area. Under the deal, Jubilant’s

The ANDA involved contributions from both Perrigo and Impax Laboratories, who will share certain costs and benefits of Astepro Nasal Spray. The spray is a prescription medicine for

Under the deal signed by Seoul National University’s College of Pharmacy and Agilent, the partnership is aimed at carrying out drug metabolism studies; research, evaluate and develop new

Acanya (clindamycin phosphate and benzoyl peroxide) Gel is a lincosamide antibiotic and benzoyl peroxide indicated for the topical treatment of acne vulgaris. As part of the deal, Valeant

The company entered into an agreement for the lease of the comprehensive facility, which will allow it to carry out research as well as manufacture microspheres for its

The project, known by the acronym "REDDSTAR" (Repair of Diabetic Damage by Stromal Cell Administration), is being coordinated by Dr Timothy O’Brien, Dean of Medicine and Director of

Under the deal, Berg’s Interrogative Biology platform will be applied to several serum, urine, and kidney data points from select individuals, both lupus patients and controls followed in